BIO Asia–Taiwan 2025 亞洲生技大會

Global CDMO Perspectives

on Outsourcing

As global economic conditions evolve, so do the strategies behind outsourcing decisions in the biopharma industry. Join us at this session for a high-level discussion featuring expert insights from both regional and international perspectives.

Highlights Include:

• Opening Remarks
  Stephen Lam, CEO, Bora Biologics

• Asia Biotech Perspective
  Jennifer Ho, VP of Research and Clinical Development, Shine-On BioMedical

• Innovations in Monoclonal Antibody Development for Infectious Diseases
  Vu Truong, CEO, Aridis Pharmaceuticals

• Global CDMO Perspective
  Marc Goemans, CCO, Bora Biologics

• Panel Discussion & Live Q&A
  Moderated by Stephen Lam with all speakers

This session brings together top decision-makers to discuss how outsourcing strategies are being reshaped in response to today’s challenges—from supply chain shifts to geopolitical pressures.

Don’t miss this opportunity to hear directly from biotech leaders shaping the future of outsourcing.

Register Now & Save $100
Deadline: July 15